| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Consulting (note 11) | 15,000 | 15,000 | ||
| Research and development (note 10) | 276 | 183 | ||
| Selling, general and administrative (notes 9 and 11) | 77,852 | 36,615 | ||
| Stock-based compensation (notes 7 and 11) | 0 | 0 | ||
| Loss from operations | 93,128 | 51,798 | ||
| Interest income | 5 | 80 | ||
| Net loss | -93,123 | -51,718 | ||
| Currency translation differences | -1,813 | -7,861 | ||
| Total comprehensive loss | -94,936 | -59,579 | ||
| Net loss per share - basic and diluted (in dollars per share) | 0 | 0 | ||
| Weighted average number of common shares outstanding basic and diluted (in shares) | 91,422,569 | 91,422,569 | ||
OCULUS INC. (OVTZ)
OCULUS INC. (OVTZ)